The largest database of trusted experimental protocols

Hiseq 1500

Manufactured by Illumina
Sourced in United States, China, Belgium, Argentina, Denmark

The HiSeq 1500 is a high-throughput DNA sequencing system designed for a wide range of genomic applications. The instrument utilizes sequencing-by-synthesis technology to generate high-quality sequencing data. The HiSeq 1500 is capable of producing up to 800 million paired-end reads per run, with read lengths up to 300 base pairs.

Automatically generated - may contain errors

478 protocols using hiseq 1500

1

Transcriptome Sequencing by Illumina and PacBio

Check if the same lab product or an alternative is used in the 5 most similar protocols
We isolated total RNA using a RNeasy plus mini kit (#74134, Qiagen, Duesseldorf, Germany). RNA quality was then assessed using EtBr-stained 0.8% agarose gels, while concentration and integrity were evaluated using an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA, USA). Transcriptome sequencing was carried out using Illumina Hiseq 1500 (Illumina, San Diego, CA, USA) and PacBio RS II systems (Pacific Biosciences, Menlo Park, CA, USA), following the manufacturer’s instructions. SMRT sequence and Illumina Hiseq 1500 data have been submitted to the Sequence Read Archive (SRA) of the NCBI database under study accession number SRP094520 of bioproject PRJNA356162.
+ Open protocol
+ Expand
2

Exome Sequencing on NextSeq 550 and HiSeq 1500

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exome sequencing was done on two platforms, HiSeq 1500 and NextSeq 550 (Illumina, San Diego, CA, USA).
For the NextSeq 550 platform, exome libraries were prepared with the TruSeq DNA Library Preparation Kit (Illumina, San Diego, CA, USA) and the xGen Exome Research Panel (IDT, Integrated DNA Technologies, Coralville, IA, USA) according to the IDT-Illumina TruSeq DNA Exome protocol (Illumina, San Diego, CA, USA). Sequencing was done using NextSeq 550 (Illumina, San Diego, CA, USA) with paired-end sequencing (150 bp) (11 (link), 12 (link)).
For the HiSeq 1500 platform, exome libraries were prepared using the Kapa Library Amplification Kit (Roche, Basel, Switzerland) and NimbleGen SeqCap EZ Exome v3.0 (Roche, Basel, Switzerland). Sequencing was performed on HiSeq 1500 (Illumina, San Diego, CA, USA) with paired-end sequencing (250 bp).
+ Open protocol
+ Expand
3

HiSeq 1500 RNA-seq and ChIP-seq Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All RNA-seq libraries and all but two ChIP-seq libraries were subjected to on-board cluster generation using HiSeq SR Rapid Cluster Kit v2 (Illumina) and sequenced on Rapid Run Mode of Illumina HiSeq 1500 (Illumina) to obtain single end 80 nt reads. Two ChIP-seq libraries (GM12878_input_rep1 and GM12878_ChIP_rep1) were subjected to cluster generation in cBot using TruSeq PE Cluster Kit v3 cBot-HS (Illumina) and sequenced in the high-output mode of HiSeq 1500 to obtain paired-end 101 nt reads. Only the forward reads from the paired-end data were used for analysis after trimming them to 80 nt, to adjust to those of the other samples. All the RNA-seq and ChIP-seq reads were processed by Trim Galore! v0.3.7 (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) at default parameters to trim reads at low quality sequences and Illumina TruSeq adaptor sequences. RNA-seq and ChIP-seq data are available at DDBJ Sequence Read Archive (DRA) under the accession DRA005605.
+ Open protocol
+ Expand
4

Whole Exome Sequencing for Genetic Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood samples were collected from 18 children and from their parents and siblings (if present). Genomic DNA was extracted using a standard protocol.
R-WES was defined as a process completed within 5–14 days of the sample collection and included transport to the laboratory, DNA isolation, sequencing, and the first analysis of the WES results. WES was performed on the proband DNA using SureSelect Human All Exon v5 (16 patients) or v7 (two patients) (Agilent Technologies, Palo Alto, CA, USA) according to the manufacturer’s instructions. The libraries were paired-end sequenced (2 × 100 bp) on the HiSeq 1500 (Illumina, San Diego, CA, USA) in Rapid Run mode and analyzed as previously described [13 (link)].
The variants considered as disease causing were validated in proband and studied in all the available family members by direct Sanger sequencing using the BigDye Terminator v3.1 Kit (Applied Biosystems, Foster City, CA, USA) on the ABI 3500Xl Genetic Analyzer (Applied Biosystems), or by amplicon deep sequencing (ADS) performed using the Nextera XT Kit (Illumina) and sequenced on the HiSeq 1500 (Illumina).
+ Open protocol
+ Expand
5

RNA-seq Library Preparation and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA quality was assessed using the Experion RNA StdSens Analysis Kit. RNA-seq libraries were prepared from total RNA using the TruSeq Stranded mRNA LT kit according to the manufacturer's instructions. Quality of sequencing libraries was controlled on a Bioanalyzer 2100 using the Agilent High Sensitivity DNA Kit. Pooled sequencing libraries were quantified with digital PCR (QuantStudio 3D) and sequenced on the HiSeq 1500 Illumina platform in Rapid-Run mode with 50 base single reads. RNAseq was performed from RNA isolated using the RNAeasy mini kit with the Illumina Truseq mRNA kit v2 on an Illumina Hiseq 1500 according to the manufacturer's instructions.
+ Open protocol
+ Expand
6

Genetic Study of NHLRC2 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
A genetic study was performed using NGS‐based whole‐exome sequencing (WES). WES was performed only in probands. Venous blood samples were collected from the probands and their families. DNA was isolated using DNeasy Blood and Tissue Kit (Qiagen) following the manufacturer's recommendations. In patient 1 and patient 2, WES was performed with SureSelectXT Human kit All Exon v7 (Agilent, Agilent Technologies), while in patient 3, Twist Human Core Exome (Twist Bioscience) was used. Then paired‐end sequenced (2x100bp) on HiSeq 1500 (Illumina). Bioinformatics analysis of raw WES data and variants prioritization were performed as previously described (Śmigiel et al., 2020 (link)). Prioritized NHLRC2 variants: (g.113876631G>T, NM_198514.4:c.442G>T, p.(D148Y) and g.113884318G>T, NM_198514.4: c.977G>T, p.(G326V) were validated in the probands and their families by deep‐amplicon sequencing (DAS) using Nextera XT Kit (Illumina) and sequenced on HiSeq 1500 (Illumina).
Runs of homozygosity (ROHs) were detected using the bcftools program as described previously (Narasimhan et al., 2016 (link); Smigiel et al., 2018 (link)). The reference group consisted of WES data from 559 unrelated Polish subjects from a local database.
+ Open protocol
+ Expand
7

Bisulfite Sequencing Library Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated with the Qiagen Blood and Tissue Kit according to the manufacturer’s instructions. 0.5% (w/w) of unmethylated lambda phage DNA (Promega) was added to the sample genomic DNA for the purpose of an unmethylated control to measure the bisulfite non-conversion frequency in each sample. Genomic DNA was fragmented with either either a Covaris S2 sonicator or a Covaris M220 sonicator to a mean length of 200 bp, then end-repaired, A-tailed, ligated to methylated Nextflex Bisulfite-Seq barcodes (Perkin Elmer) using the NxSeq AmpFREE low DNA library kit (Gene Target Solutions) and subjected to PCR amplification with KAPA HiFi Uracil+ DNA polymerase (KAPA Biosystems)56 (link). Sequencing was performed single-end on a HiSeq 1500, NextSeq 500, or paired-end on a NovaSeq 6000 (Illumina).
+ Open protocol
+ Expand
8

Illumina-based RNA-Seq Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A polyA fraction of the total RNA was conducted with RNA-Seq analysis using an Illumina HiSeq 1500 instrument, as previously described [27 (link)]. At least 10 million reads (1/50 nt) were generated. The RNA-Seq analysis was performed with the participation of ZAO Genoanalytika, Moscow, Russia.
+ Open protocol
+ Expand
9

Illumina HiSeq. 1500 DNA Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 1 µg of the extracted DNA was sequenced using Pair-end Illumina HiSeq. 1500 platform at Health in Code (A Coruña, Spain). A total of 387,524,268 reads with a read size of 100 bp were generated.
+ Open protocol
+ Expand
10

Transcriptome Analysis of Lotus Species

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples for RNA-seq analysis (n = 3) were prepared as described in the TruSeq® RNA Sample Preparation Guide (Illumina). High-performance, paired-end (2 × 100 bp) sequencing was performed on an Illumina Hiseq 1500 apparatus by the Institute of Agrobiotechnology of Rosario (Rosario, Argentina). Low-quality RNA-Seq reads (QScore < Q30) detected using FastQC (Version 0.11.2) were discarded (Andrews 2010 ). De novo assembly was performed by merging the high-quality reads using Trinity software (Grabherr et al. 2011 (link)) with a minimum contig length of 200 bases and a k-mer size of 25 bp. Functional annotation of assembled transcripts was performed by homology search (BLAST/Uniprot and SwissProt), protein domain identification (HMMER/PFAM), protein signal peptide and transmembrane domain prediction (signalP/tmHMM), and annotation databases search (eggnog/GO/Kegg) using Trinotate pipeline (Bryant et al. 2017 (link)).
The reads' FPKM (Fragments Per Kilobase Million) value was determined by the eXpress abundance estimation method (Roberts and Pachter 2013 (link)). Fold change for selected transcripts was estimated by FPKM of L. corniculatus / FPKM of L. tenuis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!